corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 18146

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Chadwick D, Gray R.
Shared scheme for assessing drugs for multiple sclerosis: dealing with uncertainties about cost effectiveness of treatments is difficult problem.
BMJ 2003 May 31; 326:(7400):1212-3
http://www.bmj.com/cgi/content/full/326/7400/1212-a?view=long&pmid=12775632

Keywords:
Azathioprine/economics* Azathioprine/therapeutic use Cost-Benefit Analysis Humans Immunosuppressive Agents/economics* Immunosuppressive Agents/therapeutic use Multiple Sclerosis/drug therapy* Risk Sharing, Financial

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend